Grazyna Kochan

6.3k total citations · 1 hit paper
94 papers, 3.5k citations indexed

About

Grazyna Kochan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Grazyna Kochan has authored 94 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 43 papers in Immunology and 30 papers in Molecular Biology. Recurrent topics in Grazyna Kochan's work include Cancer Immunotherapy and Biomarkers (34 papers), Immunotherapy and Immune Responses (27 papers) and CAR-T cell therapy research (19 papers). Grazyna Kochan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (34 papers), Immunotherapy and Immune Responses (27 papers) and CAR-T cell therapy research (19 papers). Grazyna Kochan collaborates with scholars based in Spain, United Kingdom and Belgium. Grazyna Kochan's co-authors include David Escors, Hugo Arasanz, Miren Zuazo, María Gato, Udo Oppermann, Karine Breckpot, Ana Bocanegra, Ruth Vera, Luisa Chocarro and María Ibáñez-Vea and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Grazyna Kochan

90 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis

2018 229 citations Grazyna Kochan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grazyna Kochan Spain	34	1.6k	1.4k	1.3k	308	293	94	3.5k
Sigrid Hatse Belgium	36	1.8k 1.1×	1.1k 0.8×	1.5k 1.2×	631 2.0×	227 0.8×	97	4.1k
David J. Matthews United States	28	682 0.4×	1.2k 0.9×	1.3k 1.0×	228 0.7×	168 0.6×	61	3.6k
Kerri Mowen United States	25	864 0.6×	2.4k 1.7×	2.5k 2.0×	147 0.5×	252 0.9×	33	5.3k
Christoph Driessen Switzerland	45	1.7k 1.1×	1.5k 1.1×	2.9k 2.3×	234 0.8×	223 0.8×	144	5.8k
James N. Arnold United Kingdom	24	1.4k 0.9×	2.0k 1.4×	2.5k 2.0×	79 0.3×	205 0.7×	44	4.5k
Euphemia Leung New Zealand	35	815 0.5×	1.2k 0.9×	2.2k 1.7×	174 0.6×	178 0.6×	160	4.3k
Francesca Spadaro Italy	29	608 0.4×	1.2k 0.9×	1.4k 1.1×	129 0.4×	247 0.8×	65	2.9k
Efstratios Stratikos Greece	34	1.1k 0.7×	1.1k 0.8×	1.2k 1.0×	245 0.8×	64 0.2×	99	3.2k
Robert A. Kirken United States	37	2.2k 1.4×	1.8k 1.3×	1.6k 1.3×	81 0.3×	167 0.6×	111	4.5k
Liping Wang China	24	716 0.5×	1.4k 1.0×	1.2k 1.0×	582 1.9×	179 0.6×	86	3.5k

Countries citing papers authored by Grazyna Kochan

Since Specialization

Citations

This map shows the geographic impact of Grazyna Kochan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grazyna Kochan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grazyna Kochan more than expected).

Fields of papers citing papers by Grazyna Kochan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grazyna Kochan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grazyna Kochan. The network helps show where Grazyna Kochan may publish in the future.

Co-authorship network of co-authors of Grazyna Kochan

This figure shows the co-authorship network connecting the top 25 collaborators of Grazyna Kochan. A scholar is included among the top collaborators of Grazyna Kochan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grazyna Kochan. Grazyna Kochan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2024). PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Molecular Medicine. 16(8). 1791–1816. 11 indexed citations

Les, Íñigo, et al.. (2023). Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events. Cancers. 15(5). 1629–1629. 46 indexed citations

Blanco, Ester, Luisa Chocarro, Leticia Fernández, et al.. (2023). Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International Journal of Molecular Sciences. 24(3). 2676–2676. 11 indexed citations

Arasanz, Hugo, Luisa Chocarro, Leticia Fernández, et al.. (2023). Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International Journal of Molecular Sciences. 24(12). 9855–9855. 6 indexed citations

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Cardiovascular Diseases. 12448–12448. 1 indexed citations

Garnica, Maider, Anna Aiello, Mattia Emanuela Ligotti, et al.. (2022). How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. International Journal of Molecular Sciences. 23(17). 9797–9797. 11 indexed citations

Chocarro, Luisa, Hugo Arasanz, Leticia Fernández, et al.. (2022). CAR-T Cells for the Treatment of Lung Cancer. Life. 12(4). 561–561. 14 indexed citations

Arasanz, Hugo, Ana Bocanegra, Idoia Morilla, et al.. (2022). Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 14(16). 3846–3846. 26 indexed citations

Escors, David, Ana Bocanegra, Luisa Chocarro, et al.. (2022). Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. International Journal of Molecular Sciences. 23(21). 13241–13241. 11 indexed citations

10.

Aiello, Anna, Mattia Emanuela Ligotti, Maider Garnica, et al.. (2022). How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International Journal of Molecular Sciences. 23(17). 9880–9880. 16 indexed citations

11.

Echaide, Miriam, Ibone Labiano, Ángela Fernández de Lascoiti, et al.. (2022). Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers. 14(18). 4464–4464. 9 indexed citations

12.

Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 22(7). 3736–3736. 20 indexed citations

13.

Arasanz, Hugo, Carlos Hernández, Ana Bocanegra, et al.. (2020). Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition. Cancers. 12(8). 2181–2181. 7 indexed citations

14.

Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2020). Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics. Cancers. 12(2). 344–344. 58 indexed citations

15.

Hernández, Carlos, Hugo Arasanz, Luisa Chocarro, et al.. (2020). Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International Journal of Molecular Sciences. 21(7). 2411–2411. 27 indexed citations

16.

Zuazo, Miren, Hugo Arasanz, G. Fernández-Hinojal, et al.. (2019). Functional systemic CD 4 immunity is required for clinical responses to PD ‐L1/ PD ‐1 blockade therapy. EMBO Molecular Medicine. 11(7). e10293–e10293. 143 indexed citations

17.

Bocanegra, Ana, G. Fernández-Hinojal, Hugo Arasanz, et al.. (2019). PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer. International Journal of Molecular Sciences. 20(7). 1631–1631. 62 indexed citations

18.

Zhang, Zhihong, Grazyna Kochan, Stanley S. Ng, et al.. (2011). Crystal structure of PHYHD1A, a 2OG oxygenase related to phytanoyl-CoA hydroxylase. Biochemical and Biophysical Research Communications. 408(4). 553–558. 20 indexed citations

19.

Pilka, Ewa S., F. Niesen, Wen‐Hwa Lee, et al.. (2009). Structural Basis for Substrate Specificity in Human Monomeric Carbonyl Reductases. PLoS ONE. 4(10). e7113–e7113. 50 indexed citations

20.

Kochan, Grazyna, et al.. (1994). Arrieros maragatos : poder, negocio, linaje y familia, siglos XVI-XIX. Medical Entomology and Zoology. 42(2-3). 369–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact